OS9 anticorps (AA 466-667)

N° du produit ABIN5014066

Détail du produit anti-OS9 anticorps

Antigène: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Épitope: AA 466-667

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OS9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Specificité: The antibody is a rabbit polyclonal antibody raised against OS9. It has been selected for its ability to recognize OS9 in immunohistochemical staining and western blotting.

Purification: Antigen-specific affinity chromatography

Immunogène: OS9 (Asn466-Phe667)

Isotype: IgG

Information d'application

Indications d'application:

• Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.

Commentaires:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

Détails sur OS9

Antigène: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Autre désignation: Osteosarcoma Amplified 9 (OS9) (OS9 Produits)

Synonymes: anticorps OS-9, anticorps zgc:153838, anticorps 4632413K17Rik, anticorps AU022351, anticorps Os-9, anticorps ERLEC2, anticorps OS9, endoplasmic reticulum lectin, anticorps osteosarcoma amplified 9, endoplasmic reticulum lectin, anticorps amplified in osteosarcoma, anticorps OS9, anticorps os9, anticorps Os9

Sujet: Alternative Names: ERLEC2, Amplified In Osteosarcoma, Endoplasmic Reticulum Lectin 2, Erlectin 2

Pathways: Maintenance of Protein Location, SARS-CoV-2 Protein Interactome